Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Navamedic ASA ( (DE:N1A) ).
Navamedic ASA successfully completed its rights issue, raising NOK 130 million by allocating 6,046,511 offer shares at NOK 21.50 each. The rights issue was oversubscribed by 7%, indicating strong investor interest, and the new shares are expected to be tradable on Euronext Oslo Børs from 14 October 2025, potentially enhancing the company’s market position.
More about Navamedic ASA
Navamedic ASA is a full-service provider of high-quality healthcare products catering to hospitals and pharmacies. The company leverages its scalable market access platform and local knowledge to meet specific medical needs across the Nordic countries, the Baltics, Benelux, and Greece. Headquartered in Oslo, Norway, Navamedic is listed on the Oslo Stock Exchange.
Average Trading Volume: 14,436
Current Market Cap: NOK521.6M
See more insights into N1A stock on TipRanks’ Stock Analysis page.